Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biosense Webster is a global leader in the science of diagnosing and treating cardiac arrhythmias. As a subsidiary of Johnson & Johnson MedTech, the company specializes in electrophysiology, providing advanced medical technologies such as the CARTO 3 3D Mapping System and various ablation catheters. Their products are designed to help physicians identify and treat complex heart rhythm disorders, particularly atrial fibrillation. The company maintains a significant presence in the cardiovascular device market through continuous innovation in radiofrequency and pulsed field ablation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioscience Webster.